Clinical Trials in Los Angeles

Showing 2921-2940 of 16,901 trials

VIRTUUS Children's Study

NCT03719339

The objective of the VIRTUUS Children's Study is to adapt identified and validated adult noninvasive diagnostic and prognostic biomarkers for the characterization of allograft status in pediatric recipients of kidney allografts.

Renal Transplant RejectionPediatric Kidney DiseaseEnd Stage Renal Disease+4 more

Children's Hospital of Philadelphia445 participantsStarted Aug 2017

La Jolla, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +10 more locations

COMPLETEDPhase 1/2< 1 mile

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency

NCT04722887

The purpose of this study is to evaluate the safety and tolerability of 72 milligrams per kilogram (mg/kg) and 180 mg/kg Alpha-1 15%, administered as a single-dose subcutaneous (SC) infusion and subsequently as weekly SC infusions over 8 weeks in participants with Alpha1-Antitrypsin Deficiency (AATD).

Alpha1-Antitrypsin Deficiency

Grifols Therapeutics LLC17 participantsStarted Aug 2021

Los Angeles, California, United States • Gainesville, Florida, United States • Miami, Florida, United States +2 more locations

VIRTUUS Children's Study

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency

Find Trials by Condition in Los Angeles

Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy

A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma

A Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD8965 in Healthy Participants (Including Japanese and Chinese Participants) and an Open-label Cohort to Assess the Effect of Food on the Pharmacokinetics of AZD8965 in Healthy Participants

Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

Open Label, Dose-finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Participants With Suspected or Confirmed Bacterial Infections

Quick Measure Study for iCare ST500 and iCare IC200

A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term

UNITY VCS Vitreoretinal Surgery

Evaluation of OLX10212 in Patients With Neovascular Age-related Macular Degeneration

A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease

Evaluation of A Clinical Diagnostic Test for CRDS